FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 171 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,171,000 | +175.2% | 269,986 | +24.2% | 0.00% | – |
| Q4 2020 | $3,696,000 | +5861.3% | 217,346 | +1546.6% | 0.00% | – |
| Q3 2020 | $62,000 | -88.8% | 13,200 | -85.4% | 0.00% | – |
| Q2 2020 | $553,000 | +295.0% | 90,596 | +47.3% | 0.00% | – |
| Q1 2020 | $140,000 | -55.3% | 61,514 | -9.9% | 0.00% | – |
| Q4 2019 | $313,000 | -57.4% | 68,288 | -63.9% | 0.00% | – |
| Q3 2019 | $734,000 | -61.6% | 189,290 | -40.2% | 0.00% | – |
| Q2 2019 | $1,909,000 | +154.5% | 316,330 | +464.9% | 0.00% | – |
| Q1 2019 | $750,000 | +63.4% | 56,000 | +13.6% | 0.00% | – |
| Q4 2018 | $459,000 | -79.6% | 49,300 | -69.5% | 0.00% | – |
| Q3 2018 | $2,251,000 | +100.3% | 161,700 | +127.4% | 0.00% | – |
| Q2 2018 | $1,124,000 | +20.1% | 71,100 | +30.5% | 0.00% | – |
| Q1 2018 | $936,000 | -47.9% | 54,500 | -33.5% | 0.00% | – |
| Q4 2017 | $1,795,000 | -69.0% | 81,900 | -42.2% | 0.00% | -100.0% |
| Q3 2017 | $5,793,000 | +296.8% | 141,600 | +192.0% | 0.00% | – |
| Q2 2017 | $1,460,000 | -29.5% | 48,500 | -15.4% | 0.00% | -100.0% |
| Q1 2017 | $2,071,000 | +166.5% | 57,300 | +269.7% | 0.00% | – |
| Q4 2016 | $777,000 | -76.3% | 15,500 | -75.2% | 0.00% | -100.0% |
| Q3 2016 | $3,275,000 | +5.6% | 62,400 | -16.8% | 0.00% | 0.0% |
| Q2 2016 | $3,101,000 | -7.6% | 75,000 | -9.2% | 0.00% | -50.0% |
| Q1 2016 | $3,356,000 | -49.9% | 82,600 | -48.9% | 0.00% | -33.3% |
| Q4 2015 | $6,702,000 | +590.2% | 161,500 | +156.0% | 0.00% | – |
| Q3 2015 | $971,000 | +15.7% | 63,086 | +86.8% | 0.00% | – |
| Q2 2015 | $839,000 | +16.7% | 33,777 | +7.3% | 0.00% | – |
| Q1 2015 | $719,000 | – | 31,477 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|